We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
This article has been cited by the following publications. This list is generated based on data provided by CrossRef.
Reuben, Jacqueline
Donegan, Nancy
Wortmann, Glenn
DeBiasi, Roberta
Song, Xiaoyan
Kumar, Princy
McFadden, Mary
Clagon, Sylvia
Mirdamadi, Janet
White, Diane
Harris, Jo Ellen
Browne, Angella
Hooker, Jane
Yochelson, Michael
Walker, Milena
Little, Gary
Jernigan, Gail
Hansen, Kathleen
Dockery, Brenda
Sinatro, Brendan
Blaylock, Morris
Harmon, Kimary
Iyengar, Preetha
Wagner, Trevor
and
Nelson, Jo Anne
2017.
Healthcare Antibiotic Resistance Prevalence – DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.
Infection Control & Hospital Epidemiology,
Vol. 38,
Issue. 08,
p.
921.
Address correspondence to Xiaoyan Song, PhD, MBBS, George Washington University School of Medicine and Health Sciences, 111 Michigan Ave NW, Washington, DC 20010 (xsong@childrensnational.org).
1.Centers for Disease Control and Prevention (CDC). Laboratory detection of extended-spectrum β-lactamases (ESBLs). CDC website. http://www.cdc.gov/HAI/settings/lab/lab_esbl.html. Published November 2010. Accessed January 6, 2016.
2.Centers for Disease Control and Prevention (CDC). Multidrug-resistant organism & Clostridium difficile infection (MDRO/CDI) module. CDC website. http://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf. Published January 2015. Modified April 2015. Accessed January 6, 2016.
3.Ford, CD, Lopansri, BK, Haydoura, S, et al. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia. Infect Control Hosp Epidemiol2015;36:47–53.
4.Almyroudis, NG, Lesse, AJ, Hahn, T, et al. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol2011;32:490–496.
5.Vehreschild, MJ, Hamprecht, A, Peterson, L, et al. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. J Antimicrob Chemother2014;69:3387–3392.
6.Arnan, M, Gudiol, C, Calatayud, L, et al. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis2011;30:355–360.
7.Centers for Disease Control and Prevention (CDC). Vital signs: marking healthcare safer: stop infections from lethal CRE infections now. CDC website. http://stacks.cdc.gov/view/cdc/13204. Published 2013. Accessed June 25, 2015.
Recommend this journal
Email your librarian or administrator to recommend adding this journal to your organisation's collection.